Skip to main content

PARLINFO

 

The Hon. Lillian Eva Dyck

Current Senator - Saskatchewan

Place of Birth:  North Battleford, Saskatchewan, Canada

Profession | Occupation:  activist, professor, dean (associate), scientist, researcher, neurochemist

Notes: Member of the Gordon First Nation. Cree

Contact Information

Language Preference:  English

Parliamentary Address

Senate of Canada
Ottawa, Ontario
K1A 0A4
  Toll Free: 1-800-267-7362
  Phone: 613-995-4318
  Fax: 613-995-4331
  Email: lillian.dyck@sen.parl.gc.ca

Federal Political Experience

Years of Service: 4,960 days (13 years, 6 months, 29 days)

Senate

Senatorial Division Political Affiliation at Nomination Term Appointed on the advice of
Saskatchewan New Democratic Party 2005-03-24 -   Paul Edgar Philippe Martin

Parliamentary Group

Party Term
Liberal Party of Canada 2009-01-15 -  
New Democratic Party 2005-03-24 - 2006-10-30
Independent New Democratic Party 2006-10-31 - 2009-01-14
Committees - Senate

Committee membership is shown below by session. All members who served on a committee at any time during a session are listed.

Committee Role Term
Standing Committee on Legal and Constitutional Affairs Member 42nd Parliament, 1st Session
(2015-12-03 -  )
Standing Committee on Aboriginal Peoples Chair 42nd Parliament, 1st Session
(2015-12-10 -  )
Standing Committee on Aboriginal Peoples Vice-Chair 40th Parliament, 3rd Session
(2010-03-04 - 2011-03-26)
Standing Committee on Aboriginal Peoples Vice-Chair 41st Parliament, 2nd Session
(2013-11-19 - 2015-08-02)
Standing Committee on Aboriginal Peoples Vice-Chair 41st Parliament, 1st Session
(2011-06-14 - 2013-09-13)
Standing Committee on Aboriginal Peoples Member 42nd Parliament, 1st Session
(2015-12-03 -  )
Standing Committee on Aboriginal Peoples Member 39th Parliament, 2nd Session
(2007-11-01 - 2008-09-07)
Standing Committee on Aboriginal Peoples Member 40th Parliament, 2nd Session
(2009-02-10 - 2009-12-30)
Standing Committee on Social Affairs, Science and Technology Member 40th Parliament, 2nd Session
(2009-02-10 - 2009-12-30)
Subcommittee on Cities of the Standing Senate Committee on Social Affairs, Science and Technology Member 40th Parliament, 2nd Session
(2009-02-25 - 2009-12-30)
Standing Committee on Energy, the Environment and Natural Resources Member 40th Parliament, 3rd Session
(2010-04-12 - 2010-04-14)
Standing Committee on Social Affairs, Science and Technology Member 40th Parliament, 3rd Session
(2010-03-04 - 2011-03-26)
Standing Committee on Human Rights Member 40th Parliament, 3rd Session
(2010-05-13 - 2010-08-25)
Standing Committee on Energy, the Environment and Natural Resources Member 41st Parliament, 1st Session
(2012-06-05 - 2012-06-05)
Standing Committee on Social Affairs, Science and Technology Member 41st Parliament, 1st Session
(2013-03-18 - 2013-05-01)
Standing Committee on Human Rights Member 41st Parliament, 1st Session
(2011-11-21 - 2011-11-22)
Standing Committee on Aboriginal Peoples Member 41st Parliament, 2nd Session
(2013-10-24 - 2015-08-02)
Standing Committee on Social Affairs, Science and Technology Member 41st Parliament, 2nd Session
(2013-10-24 - 2014-03-26)
Standing Committee on Aboriginal Peoples Member 39th Parliament, 1st Session
(2006-04-06 - 2007-09-14)
Standing Committee on Social Affairs, Science and Technology Member 42nd Parliament, 1st Session
(2015-12-09 -  )
Standing Committee on Fisheries and Oceans Member 42nd Parliament, 1st Session
(2015-12-03 -  )
Standing Committee on Aboriginal Peoples Member 41st Parliament, 1st Session
(2011-06-09 - 2013-09-13)

Selected Publications

The following is a select bibliography, representing key titles or contributions from the parliamentarian’s collection of published works. To learn more about this parliamentarian’s written works please consult a library near you.

Every effort has been made to ensure the accuracy of the following information. Should you find any errors please contact us via e-mail at: parlinfo@parl.gc.ca.

Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Biochemical Pharmacology. 32 (9):1519-22 May 1, 1983

Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine. Progress in Neuro-psychopharmacology & Biological Psychiatry. 7 (4):797-800 1983

Inhibition of polyphosphoinositide turnover in rat cerebral cortex by clonidine. Life Sciences. 45 (11):993-9 1989

Polymorphism of a class 3 aldehyde dehydrogenase present in human saliva and in hair roots. Alcoholism, Clinical and Experimental Research. 19 (2):420-6 Apr. 1995

Effect of deuterium substitution on the disposition of intraperitoneal tryptamine. Biochemical Pharmacology. 35 (17):2893-6 Sept. 1, 1986

Cutaneous vasomotor sensitivity to ethanol and acetaldehyde: subtypes of alcohol-flushing response among Chinese. Alcoholism, Clinical and Experimental Research. 14 (6):932-6 Dec. 1990

Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine. European Journal of Pharmacology. 69 (3):371-4 Jan. 29, 1981

Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat. Neurochemical Research. 4 (5):633-42 Oct. 1979

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase. Naunyn-Schmiedeberg's Archives of Pharmacology. 337 (3):279-83 Mar. 1988

Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine. Neurochemical Research. 9 (95):617-28 May 1984

Effects of beta-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex. Neurochemical Research. 14 (1):63-7 Jan. 1989

The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. Journal of Neuroscience Research. 10 (2):211-20 1983

Effect of monofluoromethyldopa (MFMD) on trace amine levels. Life Sciences. 40 (6):571-5 Feb. 9, 1987

Isoenzymes of aldehyde dehydrogenase in human lymphocytes. Alcoholism, Clinical and Experimental Research. 14 (4):534-8 Aug. 1990

The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. European Journal of Pharmacology. 84 (3):139-49 Oct. 22, 1982

Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum. Life Sciences. 53 (11):901-9 1993

Inibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine. Drug Metabolism and Disposition. 29 (8):1156-61 Aug. 2001

Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum. Biochemical Pharmacology. 45:1317-22 Mar. 24, 1993

Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):383-8 1982

Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine. Journal of Neurochemistry. 46 (6):1899-903 June 1986

Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sciences. 44 (17):1149-56 1989

The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum. Neurochemical Research. 7 (6):705-16 June 1982

Absence of the atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme in Saskatchewan Cree Indians. Human Heredity. 43 (2):116-20 Mar./Apr. 1993

Behavioural and neurochemical effects of meta-tyrosine in the rat. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):389-94 1982

Involvement of brain trace amines in the behavioural effects of phenelzine. Neurochemical Research. 13 (2):113-9 Feb. 1988

Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone. Journal of Neuroscience Research. 8 (1):57-65 1982

Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) _expression and localization. Journal of Neuroscience Research. 74 (6):942-7 Dec .15, 2003

Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent. Drug Metabolism and Disposition. 28 (2):147-54 Feb. 2000

Uptake and release of meta-tyramine, para-tyramine, and dopamine in rat striatal slices. Neurochemical Research. 3 (6):775-91 Dec. 1978

Dare to be brave: stand up for yourself. In : Women in the Canadian academic tundra: challenging the chill / [edited by] Elena Hannah, Linda Paul, Swani Vethamany-Globus. Montreal: McGill-Queen's University Press; p. 47-50. c2002

A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. European Journal of Pharmacology. 68 (1):33-40 Nov. 7, 1980

Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. Journal of Neuroscience Research. 81 (4):572-80. Aug. 15, 2005

Alterations in trace amine and trace acid concentrations in isolated aggressive mice. Pharmacology, Biochemistry, and Behavior. 17 (6):1291-4 Dec. 1982

Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine. Biochemical Pharmacology. 34 (1):1925-9 June 1, 1985

Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study. Journal of Neurochemistry. 46 (2):399-404 Feb. 1986

The University of Saskatchewan: a portrait. Women's Education. 9 (2):23 1991

Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Journal of Psychiatry and Neuroscience. 31 (1):32-7 Jan. 2006

Biosynthesis and excretion of meta and para tyramine in the rat. Life Sciences. 14 (12):2497-506 June 16, 1974

Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Psychopharmacology. 81 (2):122-5 1983

Reversible amine -- selective effects of acute and chronic brofaromine treatment in the rat. Life Sciences. 51 (1):59-66 1992

Microassay for the estimation of monoamine oxidase activity. Analytical Biochemistry. 72:637-42 May 7, 1976

The behavioural effects of phenelzine and phenylethylamine may be due to amine release. Brain Research Bulletin. 12 (1):23-8 Jan. 1984

Demonstration of an anti-oxidative stress mechanism of quetiapine. FEBS Journal. 275 (14):3718-28 Jul. 2008

An in vitro study of the uptake and release of m- and p-tyramine. Thesis (Ph.D.) -- University of Saskatchewan; xiii, 157 leaves. 1981

Effect of decarboxylase inhibitors on brain p-tyrosine levels. Biochemical Pharmacology. 36 (8):1373-6 Apr. 15, 1987

Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution. Progress in Neuro-psychopharmacology & Biological Psychiatry. 9 (5):675-80 1985

Hydroxylation of beta-phenylethylamine in the rat. Life Sciences. 15 (9):1673-83 Nov. 1, 1974

Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins. Neurochemical Research. 6 (4):365-75 Apr. 1981

Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices. Neurochemical Research. 14 (11):1047-52 Nov. 1989

The effect of some drugs on the urinary excretion of some aryl alkyl amines in the rat. Research Communications in Chemical Pathology and Pharmacology. 11 (1):73-7 May 1975

Identification and metabolism of certain biogenic amines in brain: a thesis submitted to the Faculty of Graduate Studies in partial fulfilment of the requirements for the degree of Master of Science in the Department of Biochemistry. Saskatoon, Sask.: s.n.; x, 95 leaves. 1970

Effect of deuterium substitution on the penetration of beta-phenylethylhydrazine into the rat brain. Biochemical Pharmacology. 37 (13):2703-4 July 1, 1988

Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugs. Advances in Pharmacology. 42:308-11 1998

Contact Information

Language Preference:  English

Parliamentary Address

Senate of Canada
Ottawa, Ontario
K1A 0A4
  Toll Free: 1-800-267-7362
  Phone: 613-995-4318
  Fax: 613-995-4331
  Email: lillian.dyck@sen.parl.gc.ca

Federal Political Experience

Years of Service: 4,960 days (13 years, 6 months, 29 days)

Senate

Senatorial Division Political Affiliation at Nomination Term Appointed on the advice of
Saskatchewan New Democratic Party 2005-03-24 -   Paul Edgar Philippe Martin

Parliamentary Group

Party Term
Liberal Party of Canada 2009-01-15 -  
New Democratic Party 2005-03-24 - 2006-10-30
Independent New Democratic Party 2006-10-31 - 2009-01-14
Committees - Senate

Committee membership is shown below by session. All members who served on a committee at any time during a session are listed.

Committee Role Term
Standing Committee on Legal and Constitutional Affairs Member 42nd Parliament, 1st Session
(2015-12-03 -  )
Standing Committee on Aboriginal Peoples Chair 42nd Parliament, 1st Session
(2015-12-10 -  )
Standing Committee on Aboriginal Peoples Vice-Chair 40th Parliament, 3rd Session
(2010-03-04 - 2011-03-26)
Standing Committee on Aboriginal Peoples Vice-Chair 41st Parliament, 2nd Session
(2013-11-19 - 2015-08-02)
Standing Committee on Aboriginal Peoples Vice-Chair 41st Parliament, 1st Session
(2011-06-14 - 2013-09-13)
Standing Committee on Aboriginal Peoples Member 42nd Parliament, 1st Session
(2015-12-03 -  )
Standing Committee on Aboriginal Peoples Member 39th Parliament, 2nd Session
(2007-11-01 - 2008-09-07)
Standing Committee on Aboriginal Peoples Member 40th Parliament, 2nd Session
(2009-02-10 - 2009-12-30)
Standing Committee on Social Affairs, Science and Technology Member 40th Parliament, 2nd Session
(2009-02-10 - 2009-12-30)
Subcommittee on Cities of the Standing Senate Committee on Social Affairs, Science and Technology Member 40th Parliament, 2nd Session
(2009-02-25 - 2009-12-30)
Standing Committee on Energy, the Environment and Natural Resources Member 40th Parliament, 3rd Session
(2010-04-12 - 2010-04-14)
Standing Committee on Social Affairs, Science and Technology Member 40th Parliament, 3rd Session
(2010-03-04 - 2011-03-26)
Standing Committee on Human Rights Member 40th Parliament, 3rd Session
(2010-05-13 - 2010-08-25)
Standing Committee on Energy, the Environment and Natural Resources Member 41st Parliament, 1st Session
(2012-06-05 - 2012-06-05)
Standing Committee on Social Affairs, Science and Technology Member 41st Parliament, 1st Session
(2013-03-18 - 2013-05-01)
Standing Committee on Human Rights Member 41st Parliament, 1st Session
(2011-11-21 - 2011-11-22)
Standing Committee on Aboriginal Peoples Member 41st Parliament, 2nd Session
(2013-10-24 - 2015-08-02)
Standing Committee on Social Affairs, Science and Technology Member 41st Parliament, 2nd Session
(2013-10-24 - 2014-03-26)
Standing Committee on Aboriginal Peoples Member 39th Parliament, 1st Session
(2006-04-06 - 2007-09-14)
Standing Committee on Social Affairs, Science and Technology Member 42nd Parliament, 1st Session
(2015-12-09 -  )
Standing Committee on Fisheries and Oceans Member 42nd Parliament, 1st Session
(2015-12-03 -  )
Standing Committee on Aboriginal Peoples Member 41st Parliament, 1st Session
(2011-06-09 - 2013-09-13)

Selected Publications

The following is a select bibliography, representing key titles or contributions from the parliamentarian’s collection of published works. To learn more about this parliamentarian’s written works please consult a library near you.

Every effort has been made to ensure the accuracy of the following information. Should you find any errors please contact us via e-mail at: parlinfo@parl.gc.ca.

Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Biochemical Pharmacology. 32 (9):1519-22 May 1, 1983

Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine. Progress in Neuro-psychopharmacology & Biological Psychiatry. 7 (4):797-800 1983

Inhibition of polyphosphoinositide turnover in rat cerebral cortex by clonidine. Life Sciences. 45 (11):993-9 1989

Polymorphism of a class 3 aldehyde dehydrogenase present in human saliva and in hair roots. Alcoholism, Clinical and Experimental Research. 19 (2):420-6 Apr. 1995

Effect of deuterium substitution on the disposition of intraperitoneal tryptamine. Biochemical Pharmacology. 35 (17):2893-6 Sept. 1, 1986

Cutaneous vasomotor sensitivity to ethanol and acetaldehyde: subtypes of alcohol-flushing response among Chinese. Alcoholism, Clinical and Experimental Research. 14 (6):932-6 Dec. 1990

Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine. European Journal of Pharmacology. 69 (3):371-4 Jan. 29, 1981

Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat. Neurochemical Research. 4 (5):633-42 Oct. 1979

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase. Naunyn-Schmiedeberg's Archives of Pharmacology. 337 (3):279-83 Mar. 1988

Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine. Neurochemical Research. 9 (95):617-28 May 1984

Effects of beta-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex. Neurochemical Research. 14 (1):63-7 Jan. 1989

The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. Journal of Neuroscience Research. 10 (2):211-20 1983

Effect of monofluoromethyldopa (MFMD) on trace amine levels. Life Sciences. 40 (6):571-5 Feb. 9, 1987

Isoenzymes of aldehyde dehydrogenase in human lymphocytes. Alcoholism, Clinical and Experimental Research. 14 (4):534-8 Aug. 1990

The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. European Journal of Pharmacology. 84 (3):139-49 Oct. 22, 1982

Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum. Life Sciences. 53 (11):901-9 1993

Inibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine. Drug Metabolism and Disposition. 29 (8):1156-61 Aug. 2001

Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum. Biochemical Pharmacology. 45:1317-22 Mar. 24, 1993

Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):383-8 1982

Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine. Journal of Neurochemistry. 46 (6):1899-903 June 1986

Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sciences. 44 (17):1149-56 1989

The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum. Neurochemical Research. 7 (6):705-16 June 1982

Absence of the atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme in Saskatchewan Cree Indians. Human Heredity. 43 (2):116-20 Mar./Apr. 1993

Behavioural and neurochemical effects of meta-tyrosine in the rat. Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):389-94 1982

Involvement of brain trace amines in the behavioural effects of phenelzine. Neurochemical Research. 13 (2):113-9 Feb. 1988

Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone. Journal of Neuroscience Research. 8 (1):57-65 1982

Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) _expression and localization. Journal of Neuroscience Research. 74 (6):942-7 Dec .15, 2003

Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent. Drug Metabolism and Disposition. 28 (2):147-54 Feb. 2000

Uptake and release of meta-tyramine, para-tyramine, and dopamine in rat striatal slices. Neurochemical Research. 3 (6):775-91 Dec. 1978

Dare to be brave: stand up for yourself. In : Women in the Canadian academic tundra: challenging the chill / [edited by] Elena Hannah, Linda Paul, Swani Vethamany-Globus. Montreal: McGill-Queen's University Press; p. 47-50. c2002

A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. European Journal of Pharmacology. 68 (1):33-40 Nov. 7, 1980

Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. Journal of Neuroscience Research. 81 (4):572-80. Aug. 15, 2005

Alterations in trace amine and trace acid concentrations in isolated aggressive mice. Pharmacology, Biochemistry, and Behavior. 17 (6):1291-4 Dec. 1982

Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine. Biochemical Pharmacology. 34 (1):1925-9 June 1, 1985

Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study. Journal of Neurochemistry. 46 (2):399-404 Feb. 1986

The University of Saskatchewan: a portrait. Women's Education. 9 (2):23 1991

Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Journal of Psychiatry and Neuroscience. 31 (1):32-7 Jan. 2006

Biosynthesis and excretion of meta and para tyramine in the rat. Life Sciences. 14 (12):2497-506 June 16, 1974

Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Psychopharmacology. 81 (2):122-5 1983

Reversible amine -- selective effects of acute and chronic brofaromine treatment in the rat. Life Sciences. 51 (1):59-66 1992

Microassay for the estimation of monoamine oxidase activity. Analytical Biochemistry. 72:637-42 May 7, 1976

The behavioural effects of phenelzine and phenylethylamine may be due to amine release. Brain Research Bulletin. 12 (1):23-8 Jan. 1984

Demonstration of an anti-oxidative stress mechanism of quetiapine. FEBS Journal. 275 (14):3718-28 Jul. 2008

An in vitro study of the uptake and release of m- and p-tyramine. Thesis (Ph.D.) -- University of Saskatchewan; xiii, 157 leaves. 1981

Effect of decarboxylase inhibitors on brain p-tyrosine levels. Biochemical Pharmacology. 36 (8):1373-6 Apr. 15, 1987

Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution. Progress in Neuro-psychopharmacology & Biological Psychiatry. 9 (5):675-80 1985

Hydroxylation of beta-phenylethylamine in the rat. Life Sciences. 15 (9):1673-83 Nov. 1, 1974

Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins. Neurochemical Research. 6 (4):365-75 Apr. 1981

Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices. Neurochemical Research. 14 (11):1047-52 Nov. 1989

The effect of some drugs on the urinary excretion of some aryl alkyl amines in the rat. Research Communications in Chemical Pathology and Pharmacology. 11 (1):73-7 May 1975

Identification and metabolism of certain biogenic amines in brain: a thesis submitted to the Faculty of Graduate Studies in partial fulfilment of the requirements for the degree of Master of Science in the Department of Biochemistry. Saskatoon, Sask.: s.n.; x, 95 leaves. 1970

Effect of deuterium substitution on the penetration of beta-phenylethylhydrazine into the rat brain. Biochemical Pharmacology. 37 (13):2703-4 July 1, 1988

Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugs. Advances in Pharmacology. 42:308-11 1998